Gamma Linolenic Acid Market Size, Growth, Trends, Report 2024-2033
Gamma Linolenic Acid (GLA) stands as an omega-6 fatty acid primarily sourced from plants like evening primrose oil, borage oil, and blackcurrant seed oil. Renowned for its diverse health advantages, GLA encompasses inflammation reduction, blood sugar level regulation, and support for skin health.
The GLA market encompasses global products derived from or containing GLA, such as cosmetics, supplements, and functional foods. Several factors drive this market, including a surging demand for natural and plant-based items, heightened consumer awareness regarding GLA's health benefits, and an uptick in chronic diseases like diabetes, cardiovascular conditions, and cancer. This has led to an increased demand for GLA supplements as an alternative therapeutic approach. Moreover, the market is experiencing growth due to the rising interest in cosmetic and personal care products featuring GLA.
Furthermore, the prevalence of rheumatoid arthritis globally is anticipated to further elevate the demand for gamma linolenic acid. Joint pain and swelling are common symptoms of arthritis, and the consumption of gamma linolenic acid is beneficial in reducing inflammation and preventing arthritis. The gamma linolenic acid market is also witnessing growth due to changing lifestyles and an increase in consumer awareness related to health issues.
Governments are increasingly mandating health supplements for the elderly population. A notable example is the South Korean government's move in March 2023, wherein they made nutritional supplements compulsory for individuals aged 65 and above. These health functional foods will incorporate six functional raw materials and must be accompanied by country of origin labeling. This stipulation falls within the framework of the Guidelines for Country of Origin labeling of Agriculture and Fishery products, encompassing 13 specific items.
The mandate extends to supplements containing gamma linolenic acid derived from borage seed, primrose seed, and blackcurrant seed. This regulation is poised to drive an uptick in the consumption of gamma linolenic acid in the country in the foreseeable future.
By Nature Type
By Form
By End-Use
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Nature Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Gamma Linolenic Acid Market
5.1. COVID-19 Landscape: Gamma Linolenic Acid Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Gamma Linolenic Acid Market, By Nature Type
8.1. Gamma Linolenic Acid Market, by Nature Type, 2024-2033
8.1.1 Conventional
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Organic
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Gamma Linolenic Acid Market, By Form
9.1. Gamma Linolenic Acid Market, by Form, 2024-2033
9.1.1. Liquid
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Powder
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Gamma Linolenic Acid Market, By End-Use
10.1. Gamma Linolenic Acid Market, by End-Use, 2024-2033
10.1.1. Animal Nutrition
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Pharmaceutical Industry
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Cosmetic
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Personal Care
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Food & Beverage
10.1.5.1. Market Revenue and Forecast (2021-2033)
10.1.6. Dietary Supplements
10.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Gamma Linolenic Acid Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.1.2. Market Revenue and Forecast, by Form (2021-2033)
11.1.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Form (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Form (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.2.2. Market Revenue and Forecast, by Form (2021-2033)
11.2.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Form (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Form (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Form (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Form (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.3.2. Market Revenue and Forecast, by Form (2021-2033)
11.3.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Form (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Form (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Form (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Form (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.4.2. Market Revenue and Forecast, by Form (2021-2033)
11.4.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Form (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Form (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Form (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Form (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.5.2. Market Revenue and Forecast, by Form (2021-2033)
11.5.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Form (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End-Use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Nature Type (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Form (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End-Use (2021-2033)
Chapter 12. Company Profiles
12.1. Merck KGaA.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cayman Chemical.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Enzo Life Sciences Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cherish Pharma.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Thermo Fisher Scientific.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Changsha Vigorous-Tech
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Penta Manufacturing.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Caila & Pares
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Acme.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Xi'an Sonwu Biotech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers